-

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Playtika Holding Corp. (NASDAQ: PLTK) and Encourages PLTK Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Playtika Holding Corp. (NASDAQ: PLTK) on behalf of the Company’s stockholders.

The investigation seeks to determine whether Playtika issued false and misleading statements and/or failed to disclose material facts to investors, thereby violating the securities laws and causing harm to the company’s shareholders.

Current Playtika shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/playtika/, for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation, and has helped recover in excess of $150 million on behalf of victimized investors. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

Contacts

D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Industry:

Kaskela Law LLC

NASDAQ:PLTK
Release Versions
English

Contacts

D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company’s shares. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a pr...

CWAN STOCKHOLDER NOTE: Kaskela Law Firm Announces Investigation into Clearwater Analytics Holdings, Inc. Stockholder Buyout and Encourages Investors to Contact the Firm – CWAN

PHILADELPHIA--(BUSINESS WIRE)--On behalf of Clearwater Analytics Holdings, Inc. (NYSE: CWAN) (“Clearwater”) stockholders, Kaskela Law LLC announces that it is actively investigating the recently announced proposed buyout of Clearwater’s investors to determine whether the buyout price provides investors with sufficient monetary consideration for their shares. Click here to request additional information: https://kaskelalaw.com/case/clearwater-analytics-buyout/ On December 21, 2025, Clearwater an...

ONESTREAM SHAREHOLDER NOTE: Kaskela Law Firm Announces Investigation of OneStream, Inc. Shareholder Buyout Proposal and Encourages Investors to Contact the Firm – OS

PHILADELPHIA--(BUSINESS WIRE)--On behalf of OneStream, Inc. (NASDAQ: OS) investors, Kaskela Law LLC announces that it is investigating the recently announced proposed buyout of OneStream’s shareholders to determine whether the buyout price provides investors with a high enough buyout price for their OneStream shares. Click here to request additional information: https://kaskelalaw.com/case/onestream/ On January 6, 2026, OneStream announced that it had agreed to be acquired by private equity fir...
Back to Newsroom